3 not yet recruiting, 2 completed, 2 recruiting, 1 unknown. 4 Phase 4, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Not yet recruiting 2, Recruiting 2 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Silodosin 8 mg: new trials by email Literature Review of Silodosin 8 mg trials Research Report on Silodosin 8 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Randomized Cross-Over Study Evaluating the Efficacy and Safety of Silodosin in Adult Women With Voiding Dysfunction Silodosin 8 mg, Placebo - Voiding Dysfunction, Female LUTS | Phase 2 | Not yet recruiting | Jaber Al Ahmad Al Sabah Hospital | 150 | 2026-10-01 | 2026-09-16 |
| Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Silodosin | Phase 4 | Not yet recruiting | Mohsen Pourazizi | 40 | 2026-08-01 | 2026-08-03 |
| Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Tamsulosin | Phase 4 | Not yet recruiting | Mohsen Pourazizi | 40 | 2026-08-01 | 2026-08-03 |
| Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention Tamsulosin 0.4 mg, Tamsulosin 0.8 mg, Silodosin 8 mg - Acute Urinary Retention, Benign Prostatic Hyperplasia | Phase 4 | Recruiting | Beni-Suef University | 378 | 2026-06-08 | 2026-06-16 |
| Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis Silodosin 8 mg, Placebo - Multiple Sclerosis, Lower Urinary Track Symptoms | Phase 4 | Recruiting | Atlantic Health System | 60 | 2026-04-01 | 2026-05-29 |
| Silodosin in Retrograde Intrarenal Surgery Silodosin 8 mg, Placebo - Urolithiasis | Phase 3 | Completed | Ain Shams University | 60 | 2023-04-04 | 2024-07-16 |
| Efficacy and Safety of Silodosin in the Treatment of Lower Urinary Tract Symptoms in Taiwanese Population. Silodosin 8 mg - Human Trichinellosis | Unknown | Kaohsiung Medical University Chung-Ho Memorial Hospital | 70 | 2022-02-18 | 2024-03-27 | |
| Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Silodosin 8 mg, Placebo, Silodosin 4 mg - Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome | Phase 2 | Completed | Watson Pharmaceuticals | 153 | 2008-09-01 | 2012-02-24 |
Prostatic Hyperplasia (3) · Iris Diseases (2) · Multiple Sclerosis (1) · Prostatitis (1) · Trichinellosis (1) · Urolithiasis (1)
Mohsen Pourazizi (2) · Ain Shams University (1) · Atlantic Health System (1) · Beni-Suef University (1) · Jaber Al Ahmad Al Sabah Hospital (1) · Kaohsiung Medical University Chung-Ho Memorial Hospital (1) · Watson Pharmaceuticals (1)
Egypt (2) · United States (2) · Kuwait (1) · Taiwan (1)
Kim Caramelli, MS (1) · Meshari F Almutairi, BMBCh KBU (1) · Mohsen Pourazizi (1) · Mohsen Pourazizi, Assistant Professor (1) · Said M Yaiesh, BMBCh MSurg MSurgEd KBU (1) · Tariq F Al-Shaiji, BMBCh FRCSC (1)